These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Intracutaneous versus intramuscular hepatitis B vaccination in primary non-responding haemodialysis patients. Chang PC; Schrander-van der Meer AM; van Dorp WT; van Leer E Nephrol Dial Transplant; 1996 Jan; 11(1):191-3. PubMed ID: 8649634 [TBL] [Abstract][Full Text] [Related]
45. Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies. Fabrizi F; Dixit V; Martin P; Messa P J Viral Hepat; 2011 Dec; 18(12):871-6. PubMed ID: 22093033 [TBL] [Abstract][Full Text] [Related]
46. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. Szmuness W; Stevens CE; Harley EJ; Zang EA; Oleszko WR; William DC; Sadovsky R; Morrison JM; Kellner A N Engl J Med; 1980 Oct; 303(15):833-41. PubMed ID: 6997738 [TBL] [Abstract][Full Text] [Related]
47. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Fabrizi F; Martin P; Dixit V; Bunnapradist S; Dulai G Aliment Pharmacol Ther; 2004 Nov; 20(10):1053-62. PubMed ID: 15569107 [TBL] [Abstract][Full Text] [Related]
48. [Experiences with active vaccination against hepatitis B]. Horak W; Leithner C; Kemenesi W; Pinggera W Wien Med Wochenschr; 1983 Feb; 133(3):85-6. PubMed ID: 6845738 [No Abstract] [Full Text] [Related]
49. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients. Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664 [TBL] [Abstract][Full Text] [Related]
50. The newly licensed hepatitis B vaccine. Characteristics and indications for use. Krugman S JAMA; 1982 Apr; 247(14):2012-5. PubMed ID: 7038174 [TBL] [Abstract][Full Text] [Related]
52. Immunization against hepatitis B. Gocke DJ Adv Intern Med; 1984; 29():1-23. PubMed ID: 6231841 [No Abstract] [Full Text] [Related]
53. Active immunization against hepatitis B infection of a haemodialysis population. George J; John GT; Jacob CK; Shastry JC Natl Med J India; 1994; 7(3):115-6. PubMed ID: 7710488 [TBL] [Abstract][Full Text] [Related]
54. [Hepatitis B vaccination in dialysis patients: reversibility of defective immune response by simultaneous administration of interleukin 2]. Zeitz M Z Gastroenterol; 1990 Mar; 28(3):179-80. PubMed ID: 2140478 [No Abstract] [Full Text] [Related]
55. Evaluation of treatments for the vaccination against hepatitis B + thymopentine. Ervo R; Faletti P; Magni S; Cavatorta F Nephron; 1992; 61(3):371-2. PubMed ID: 1386912 [TBL] [Abstract][Full Text] [Related]
56. [Eradication of hepatitis B in dialysed patients through repeated sero vaccinations]. Michel P; Janin G; Chevallier P; Girard P; Laville M; Trepo C Nephrologie; 1986; 7(3):114-7. PubMed ID: 2945996 [TBL] [Abstract][Full Text] [Related]
57. [Hepatitis B vaccination in patients on chronic hemodialysis]. Kovacić V; Sain M; Vukman V Lijec Vjesn; 2003; 125(5-6):156-8. PubMed ID: 14533468 [TBL] [Abstract][Full Text] [Related]
58. Immunogenicity of a recombinant hepatitis B vaccine in haemodialysis patients. Bruguera M; Cremades M; Mayor A; Sánchez Tapias JM; Rodés J Postgrad Med J; 1987; 63 Suppl 2():155-8. PubMed ID: 3317354 [TBL] [Abstract][Full Text] [Related]
59. [Active immunoprophylaxis of type B viral hepatitis]. Spiga L; Mela GS G Clin Med; 1984; 65(5-6):237-49. PubMed ID: 6236122 [No Abstract] [Full Text] [Related]